NDC 42571-259-32 - ROFLUMILAST
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42571-259
- Requested NDC
- 42571-259-32
- Package NDCs from labels
- 42571-259-30, 42571-259-90, 42571-259-05, 42571-259-32, 42571-259-17
- Manufacturer
- Micro Labs Limited
- Effective date
- 2025-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ROFLUMILAST - Micro Labs Limited | Micro Labs Limited | 2025-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
| ROFLUMILAST - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42571-259-05 | ROFLUMILAST | 500 in 1 BOTTLE | TABLET | 500 | 6 | |
| 42571-259-17 | ROFLUMILAST | 11 in 1 CARTON | TABLET | 11 | 6 | |
| 42571-259-30 | ROFLUMILAST | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 42571-259-32 | ROFLUMILAST | 10 in 1 BLISTER PACK | TABLET | 10 | 6 | |
| 42571-259-90 | ROFLUMILAST | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42571-259-30 | EA - Each | 42571-259 | 9348a71a-7cca-4193-a549-dbeaaf99913c | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Roflumilast | ROFLUMILAST | Camber Pharmaceuticals, Inc. | f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | 2023-04-28 | Warnings, Adverse reactions | 2001319 1091839 0P6C6ZOP5U |
| ROFLUMILAST | ROFLUMILAST | Solco Healthcare US, LLC. | 4251c764-7224-4f94-9de7-b6c76cb1f5cd | 2022-05-10 | Warnings, Adverse reactions | 1091839 0P6C6ZOP5U |
| Daliresp | ROFLUMILAST | AstraZeneca Pharmaceuticals LP | c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | 2020-03-12 | Warnings, Adverse reactions | 2001319 1091839 0P6C6ZOP5U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.